TPIV: News! TapImmune issued highly valuable T-cell patent.
$TPIV New Patent 9,364,523 is a very valuable Patent for immunologists and has considerable potential to be used directly by TPIV as well as licensed to Major Pharmas currently doing R&D such as BMY, MRK, Roche/Genentech, AZN etc.
TPIV @ .50s now.
Immuno/oncology patent plays are red hot in bio/pharma sector